ReviewCancer cell international2022
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope.
Vamika Karn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ReviewCancer cell international2022
Vamika Karn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.